Company profile: Tesaro
1.1 - Company Overview
Company description
- Provider of oncology-focused biopharmaceutical solutions dedicated to improving the lives of cancer patients, leveraging management expertise to identify, acquire and develop promising drug candidates and to commercialize safer, more effective cancer therapies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tesaro
Sesen Bio
HQ: United States
Website
- Description: Provider of protein-based therapeutics focused on improving human health, including Vicineum, a locally administered targeted fusion protein for BCG-unresponsive non-muscle invasive bladder cancer, and VB6-845d, an anti-PSMA humabody-deBouganin fusion protein designed for tumor cell killing and overcoming drug resistance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sesen Bio company profile →
Theolytics
HQ: United Kingdom
Website
- Description: Provider of next-generation viral therapies, leveraging phenotypic screening platforms to discover targeted oncolytic adenoviral candidates suitable for intravenous delivery and optimized for specific patient populations. Offerings include THEO-260 for platinum-resistant ovarian cancer, THEO-310 for multiple myeloma, proprietary adenovirus libraries for oncology, gene therapy and infectious diseases, and bioselection/screening systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Theolytics company profile →
XinThera
HQ: United States
Website
- Description: Provider of drug discovery focused on building a small molecule oncology and immunology pipeline.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XinThera company profile →
Oxford Cancer Biomarkers
HQ: United Kingdom
Website
- Description: Provider of colorectal cancer biomarker tests, developing and commercializing a suite of diagnostics to improve the current treatment pathway; closely affiliated with the Institute of Cancer Medicine at Oxford University, where its founders lead translational cancer science research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford Cancer Biomarkers company profile →
Potenza Therapeutics
HQ: United States
Website
- Description: Provider of preclinical-stage biotechnology oncology programs that utilize the body's own immune system to seek out, recognize, and destroy tumors through diverse mechanisms influencing tumor immunity; founded in 2014 and headquartered in Cambridge, Massachusetts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Potenza Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tesaro
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tesaro
2.2 - Growth funds investing in similar companies to Tesaro
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tesaro
4.2 - Public trading comparable groups for Tesaro
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →